The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance

Signaling pathway alterations are important in the development of gastric cancer (GC). Deregulation of the PI3K/AKT/mTOR pathway plays a crucial role in the regulation of multiple cellular functions including cell growth, proliferation, metabolism, and angiogenesis. Our goal was to assess expression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virchows Archiv : an international journal of pathology 2014-07, Vol.465 (1), p.25-33
Hauptverfasser: Tapia, Oscar, Riquelme, Ismael, Leal, Pamela, Sandoval, Alejandra, Aedo, Susana, Weber, Helga, Letelier, Pablo, Bellolio, Enrique, Villaseca, Miguel, Garcia, Patricia, Roa, Juan Carlos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 33
container_issue 1
container_start_page 25
container_title Virchows Archiv : an international journal of pathology
container_volume 465
creator Tapia, Oscar
Riquelme, Ismael
Leal, Pamela
Sandoval, Alejandra
Aedo, Susana
Weber, Helga
Letelier, Pablo
Bellolio, Enrique
Villaseca, Miguel
Garcia, Patricia
Roa, Juan Carlos
description Signaling pathway alterations are important in the development of gastric cancer (GC). Deregulation of the PI3K/AKT/mTOR pathway plays a crucial role in the regulation of multiple cellular functions including cell growth, proliferation, metabolism, and angiogenesis. Our goal was to assess expression of proteins involved in the PI3K/AKT/mTOR pathway by immunohistochemistry (IHC) in tumor and nontumor gastric mucosa from patients with advanced GC. We evaluated 71 tumor and 71 nontumor gastric mucosa samples from advanced GC patients, selected from Hernán Henríquez Aravena Hospital (Temuco, Chile). The targets studied were PI3K, AKT, p-AKT, PTEN, mTOR, p-mTOR, P70S6K1, p-P70S6K1, 4E-BP1, p-4E-BP1, eIF4E, and p-eIF4E. Expression data were correlated with clinicomorphological data. Descriptive and analytical statistics were used (95 % confidence interval, p  
doi_str_mv 10.1007/s00428-014-1588-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1542296091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1542296091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-510b63f20e36a6e07efea48d89631c0768bb4278968b4b8ad4c984b8fec32c903</originalsourceid><addsrcrecordid>eNp1kU9rGzEQxUVIaVy3HyCXIMill61Hf3ZXezQmTYIDKcU9C6121paxtY4kJ-TbR47dUgo9SYN-72lmHiGXDL4xgHoSASRXBTBZsFKpQp6REZOCF1xAfU5G0MiyqASrL8inGNcAnClWfSQXXCopOZQj4hcrpD_uxXwynS8m28XjT7ozafViXqmL1Njknk3CjjpPlyam4Cy1xlsM9MWlFd0NCX1yZkN3YVj6IaYMGN_lEjt3UCONbuld795ln8mH3mwifjmdY_Lr-81idlc8PN7ez6YPhZVQpqJk0Fai54CiMhVCjT0aqTrV5Gks1JVqW8nrXKpWtsp00jYqX3q0gtsGxJh8Pfrmtp72GJPeumhxszEeh33UrJScNxU0LKPX_6DrYR987u5AsVowAWWm2JGyYYgxYK93wW1NeNUM9CEMfQxD5zD0IQwts-bq5Lxvt9j9Ufzefgb4EYj5yS8x_PX1f13fAM1Uk8o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1541731305</pqid></control><display><type>article</type><title>The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Tapia, Oscar ; Riquelme, Ismael ; Leal, Pamela ; Sandoval, Alejandra ; Aedo, Susana ; Weber, Helga ; Letelier, Pablo ; Bellolio, Enrique ; Villaseca, Miguel ; Garcia, Patricia ; Roa, Juan Carlos</creator><creatorcontrib>Tapia, Oscar ; Riquelme, Ismael ; Leal, Pamela ; Sandoval, Alejandra ; Aedo, Susana ; Weber, Helga ; Letelier, Pablo ; Bellolio, Enrique ; Villaseca, Miguel ; Garcia, Patricia ; Roa, Juan Carlos</creatorcontrib><description>Signaling pathway alterations are important in the development of gastric cancer (GC). Deregulation of the PI3K/AKT/mTOR pathway plays a crucial role in the regulation of multiple cellular functions including cell growth, proliferation, metabolism, and angiogenesis. Our goal was to assess expression of proteins involved in the PI3K/AKT/mTOR pathway by immunohistochemistry (IHC) in tumor and nontumor gastric mucosa from patients with advanced GC. We evaluated 71 tumor and 71 nontumor gastric mucosa samples from advanced GC patients, selected from Hernán Henríquez Aravena Hospital (Temuco, Chile). The targets studied were PI3K, AKT, p-AKT, PTEN, mTOR, p-mTOR, P70S6K1, p-P70S6K1, 4E-BP1, p-4E-BP1, eIF4E, and p-eIF4E. Expression data were correlated with clinicomorphological data. Descriptive and analytical statistics were used (95 % confidence interval, p  &lt; 0.05). For survival analyses, the Kaplan–Meier method and the log-rank test were used. PI3K, AKT, p-AKT, p-mTOR, p-4E-BP1, P70S6K1, p-P70S6K1, eIF-4E, and p-eIF-4E proteins were significantly overexpressed in tumor tissue. Conversely, PTEN was underexpressed in tumor tissue, notably in pT3-pT4 tumors ( p  = 0.02) and tumors with lymph node metastases ( p  &lt; 0.001). P70S6K1 expression was associated with pT3-pT4 tumors ( p  = 0.03). Moreover, PI3K ( p  = 0.004), AKT ( p  = 0.01), p-AKT ( p  = 0.01), P70S6K1 ( p  = 0.04), p-P70S6K1 ( p  = 0.001), and eIF-4E ( p  = 0.004) were overexpressed in tumors with lymph node metastases. Low expression of 4E-BP1 was associated with poor overall survival ( p  = 0.03). Our results suggest that the PI3K/AKT/mTOR pathway is activated in GC, with overexpression in tumor tissue of most of the studied proteins (total and phosphorylated). These might be considered as target for specific targeted therapy in GC.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-014-1588-4</identifier><identifier>PMID: 24844205</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adaptor Proteins, Signal Transducing - biosynthesis ; Aged ; Case-Control Studies ; Deregulation ; Female ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis - physiopathology ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Original Article ; Pathology ; Phosphatidylinositol 3-Kinases - metabolism ; Phosphoproteins - biosynthesis ; Prognosis ; Proto-Oncogene Proteins c-akt - metabolism ; Signal Transduction ; Stomach Neoplasms - mortality ; Stomach Neoplasms - pathology ; Stomach Neoplasms - physiopathology ; TOR Serine-Threonine Kinases - metabolism ; Tumors</subject><ispartof>Virchows Archiv : an international journal of pathology, 2014-07, Vol.465 (1), p.25-33</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-510b63f20e36a6e07efea48d89631c0768bb4278968b4b8ad4c984b8fec32c903</citedby><cites>FETCH-LOGICAL-c405t-510b63f20e36a6e07efea48d89631c0768bb4278968b4b8ad4c984b8fec32c903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00428-014-1588-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00428-014-1588-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24844205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tapia, Oscar</creatorcontrib><creatorcontrib>Riquelme, Ismael</creatorcontrib><creatorcontrib>Leal, Pamela</creatorcontrib><creatorcontrib>Sandoval, Alejandra</creatorcontrib><creatorcontrib>Aedo, Susana</creatorcontrib><creatorcontrib>Weber, Helga</creatorcontrib><creatorcontrib>Letelier, Pablo</creatorcontrib><creatorcontrib>Bellolio, Enrique</creatorcontrib><creatorcontrib>Villaseca, Miguel</creatorcontrib><creatorcontrib>Garcia, Patricia</creatorcontrib><creatorcontrib>Roa, Juan Carlos</creatorcontrib><title>The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><addtitle>Virchows Arch</addtitle><description>Signaling pathway alterations are important in the development of gastric cancer (GC). Deregulation of the PI3K/AKT/mTOR pathway plays a crucial role in the regulation of multiple cellular functions including cell growth, proliferation, metabolism, and angiogenesis. Our goal was to assess expression of proteins involved in the PI3K/AKT/mTOR pathway by immunohistochemistry (IHC) in tumor and nontumor gastric mucosa from patients with advanced GC. We evaluated 71 tumor and 71 nontumor gastric mucosa samples from advanced GC patients, selected from Hernán Henríquez Aravena Hospital (Temuco, Chile). The targets studied were PI3K, AKT, p-AKT, PTEN, mTOR, p-mTOR, P70S6K1, p-P70S6K1, 4E-BP1, p-4E-BP1, eIF4E, and p-eIF4E. Expression data were correlated with clinicomorphological data. Descriptive and analytical statistics were used (95 % confidence interval, p  &lt; 0.05). For survival analyses, the Kaplan–Meier method and the log-rank test were used. PI3K, AKT, p-AKT, p-mTOR, p-4E-BP1, P70S6K1, p-P70S6K1, eIF-4E, and p-eIF-4E proteins were significantly overexpressed in tumor tissue. Conversely, PTEN was underexpressed in tumor tissue, notably in pT3-pT4 tumors ( p  = 0.02) and tumors with lymph node metastases ( p  &lt; 0.001). P70S6K1 expression was associated with pT3-pT4 tumors ( p  = 0.03). Moreover, PI3K ( p  = 0.004), AKT ( p  = 0.01), p-AKT ( p  = 0.01), P70S6K1 ( p  = 0.04), p-P70S6K1 ( p  = 0.001), and eIF-4E ( p  = 0.004) were overexpressed in tumors with lymph node metastases. Low expression of 4E-BP1 was associated with poor overall survival ( p  = 0.03). Our results suggest that the PI3K/AKT/mTOR pathway is activated in GC, with overexpression in tumor tissue of most of the studied proteins (total and phosphorylated). These might be considered as target for specific targeted therapy in GC.</description><subject>Adaptor Proteins, Signal Transducing - biosynthesis</subject><subject>Aged</subject><subject>Case-Control Studies</subject><subject>Deregulation</subject><subject>Female</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymphatic Metastasis - physiopathology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Pathology</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Phosphoproteins - biosynthesis</subject><subject>Prognosis</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Signal Transduction</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - physiopathology</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Tumors</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU9rGzEQxUVIaVy3HyCXIMill61Hf3ZXezQmTYIDKcU9C6121paxtY4kJ-TbR47dUgo9SYN-72lmHiGXDL4xgHoSASRXBTBZsFKpQp6REZOCF1xAfU5G0MiyqASrL8inGNcAnClWfSQXXCopOZQj4hcrpD_uxXwynS8m28XjT7ozafViXqmL1Njknk3CjjpPlyam4Cy1xlsM9MWlFd0NCX1yZkN3YVj6IaYMGN_lEjt3UCONbuld795ln8mH3mwifjmdY_Lr-81idlc8PN7ez6YPhZVQpqJk0Fai54CiMhVCjT0aqTrV5Gks1JVqW8nrXKpWtsp00jYqX3q0gtsGxJh8Pfrmtp72GJPeumhxszEeh33UrJScNxU0LKPX_6DrYR987u5AsVowAWWm2JGyYYgxYK93wW1NeNUM9CEMfQxD5zD0IQwts-bq5Lxvt9j9Ufzefgb4EYj5yS8x_PX1f13fAM1Uk8o</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Tapia, Oscar</creator><creator>Riquelme, Ismael</creator><creator>Leal, Pamela</creator><creator>Sandoval, Alejandra</creator><creator>Aedo, Susana</creator><creator>Weber, Helga</creator><creator>Letelier, Pablo</creator><creator>Bellolio, Enrique</creator><creator>Villaseca, Miguel</creator><creator>Garcia, Patricia</creator><creator>Roa, Juan Carlos</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140701</creationdate><title>The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance</title><author>Tapia, Oscar ; Riquelme, Ismael ; Leal, Pamela ; Sandoval, Alejandra ; Aedo, Susana ; Weber, Helga ; Letelier, Pablo ; Bellolio, Enrique ; Villaseca, Miguel ; Garcia, Patricia ; Roa, Juan Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-510b63f20e36a6e07efea48d89631c0768bb4278968b4b8ad4c984b8fec32c903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adaptor Proteins, Signal Transducing - biosynthesis</topic><topic>Aged</topic><topic>Case-Control Studies</topic><topic>Deregulation</topic><topic>Female</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymphatic Metastasis - physiopathology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Pathology</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Phosphoproteins - biosynthesis</topic><topic>Prognosis</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Signal Transduction</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - physiopathology</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tapia, Oscar</creatorcontrib><creatorcontrib>Riquelme, Ismael</creatorcontrib><creatorcontrib>Leal, Pamela</creatorcontrib><creatorcontrib>Sandoval, Alejandra</creatorcontrib><creatorcontrib>Aedo, Susana</creatorcontrib><creatorcontrib>Weber, Helga</creatorcontrib><creatorcontrib>Letelier, Pablo</creatorcontrib><creatorcontrib>Bellolio, Enrique</creatorcontrib><creatorcontrib>Villaseca, Miguel</creatorcontrib><creatorcontrib>Garcia, Patricia</creatorcontrib><creatorcontrib>Roa, Juan Carlos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tapia, Oscar</au><au>Riquelme, Ismael</au><au>Leal, Pamela</au><au>Sandoval, Alejandra</au><au>Aedo, Susana</au><au>Weber, Helga</au><au>Letelier, Pablo</au><au>Bellolio, Enrique</au><au>Villaseca, Miguel</au><au>Garcia, Patricia</au><au>Roa, Juan Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><stitle>Virchows Arch</stitle><addtitle>Virchows Arch</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>465</volume><issue>1</issue><spage>25</spage><epage>33</epage><pages>25-33</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>Signaling pathway alterations are important in the development of gastric cancer (GC). Deregulation of the PI3K/AKT/mTOR pathway plays a crucial role in the regulation of multiple cellular functions including cell growth, proliferation, metabolism, and angiogenesis. Our goal was to assess expression of proteins involved in the PI3K/AKT/mTOR pathway by immunohistochemistry (IHC) in tumor and nontumor gastric mucosa from patients with advanced GC. We evaluated 71 tumor and 71 nontumor gastric mucosa samples from advanced GC patients, selected from Hernán Henríquez Aravena Hospital (Temuco, Chile). The targets studied were PI3K, AKT, p-AKT, PTEN, mTOR, p-mTOR, P70S6K1, p-P70S6K1, 4E-BP1, p-4E-BP1, eIF4E, and p-eIF4E. Expression data were correlated with clinicomorphological data. Descriptive and analytical statistics were used (95 % confidence interval, p  &lt; 0.05). For survival analyses, the Kaplan–Meier method and the log-rank test were used. PI3K, AKT, p-AKT, p-mTOR, p-4E-BP1, P70S6K1, p-P70S6K1, eIF-4E, and p-eIF-4E proteins were significantly overexpressed in tumor tissue. Conversely, PTEN was underexpressed in tumor tissue, notably in pT3-pT4 tumors ( p  = 0.02) and tumors with lymph node metastases ( p  &lt; 0.001). P70S6K1 expression was associated with pT3-pT4 tumors ( p  = 0.03). Moreover, PI3K ( p  = 0.004), AKT ( p  = 0.01), p-AKT ( p  = 0.01), P70S6K1 ( p  = 0.04), p-P70S6K1 ( p  = 0.001), and eIF-4E ( p  = 0.004) were overexpressed in tumors with lymph node metastases. Low expression of 4E-BP1 was associated with poor overall survival ( p  = 0.03). Our results suggest that the PI3K/AKT/mTOR pathway is activated in GC, with overexpression in tumor tissue of most of the studied proteins (total and phosphorylated). These might be considered as target for specific targeted therapy in GC.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24844205</pmid><doi>10.1007/s00428-014-1588-4</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0945-6317
ispartof Virchows Archiv : an international journal of pathology, 2014-07, Vol.465 (1), p.25-33
issn 0945-6317
1432-2307
language eng
recordid cdi_proquest_miscellaneous_1542296091
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adaptor Proteins, Signal Transducing - biosynthesis
Aged
Case-Control Studies
Deregulation
Female
Humans
Kaplan-Meier Estimate
Lymphatic Metastasis - physiopathology
Male
Medicine
Medicine & Public Health
Middle Aged
Original Article
Pathology
Phosphatidylinositol 3-Kinases - metabolism
Phosphoproteins - biosynthesis
Prognosis
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction
Stomach Neoplasms - mortality
Stomach Neoplasms - pathology
Stomach Neoplasms - physiopathology
TOR Serine-Threonine Kinases - metabolism
Tumors
title The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A47%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PI3K/AKT/mTOR%20pathway%20is%20activated%20in%20gastric%20cancer%20with%20potential%20prognostic%20and%20predictive%20significance&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=Tapia,%20Oscar&rft.date=2014-07-01&rft.volume=465&rft.issue=1&rft.spage=25&rft.epage=33&rft.pages=25-33&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-014-1588-4&rft_dat=%3Cproquest_cross%3E1542296091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1541731305&rft_id=info:pmid/24844205&rfr_iscdi=true